Dura Pharmaceuticals, Inc. v. Broudo

BVLaw
Full Text of Court Cases
April 19, 2005
2834 Pharmaceutical Preparations
325412 Pharmaceutical Preparation Manufacturing
securities litigation

Dura Pharmaceuticals, Inc. v. Broudo
544 U.S. 336 (2005)
US
Federal Court
Supreme Court
Breyer

Summary

U.S. Supreme Court establishes the loss causation requirement in securities fraud litigation; i.e., it requires the plaintiffs to provide direct, causal link between alleged fraud and/or misrerpresentation by the corporate defendants and the inflated mark ...
Dura Pharmaceuticals, Inc. v. Broudo
PDF, Size: 66 KB